High-Dose Aspirin Is Associated with Anemia and Does Not Confer Benefit to Disease Outcomes in Kawasaki Disease.

Interferon-gamma Genetic Polymorphism and Expression in Kawasaki Disease. Medicine (Baltimore) (2016) 0.81

Hepcidin-Induced Iron Deficiency Is Related to Transient Anemia and Hypoferremia in Kawasaki Disease Patients. Int J Mol Sci (2016) 0.80

Plasma Prostaglandin E2 Levels Correlated with the Prevention of Intravenous Immunoglobulin Resistance and Coronary Artery Lesions Formation via CD40L in Kawasaki Disease. PLoS One (2016) 0.79

Identifying genetic hypomethylation and upregulation of toll-like receptors in Kawasaki disease. Oncotarget (2017) 0.77

Anemia in Kawasaki Disease: Hepcidin as a Potential Biomarker. Int J Mol Sci (2017) 0.75

Epigenetic hypomethylation and upregulation of matrix metalloproteinase 9 in Kawasaki disease. Oncotarget (2017) 0.75

Correlation of HAMP gene polymorphisms and expression with the susceptibility and length of hospital stays in Taiwanese children with Kawasaki disease. Oncotarget (2017) 0.75

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation (2004) 11.41

A new infantile acute febrile mucocutaneous lymph node syndrome (MLNS) prevailing in Japan. Pediatrics (1974) 9.97

Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics (2004) 8.10

A single intravenous infusion of gamma globulin as compared with four infusions in the treatment of acute Kawasaki syndrome. N Engl J Med (1991) 5.76

Kawasaki syndrome. Lancet (2004) 5.09

The treatment of Kawasaki syndrome with intravenous gamma globulin. N Engl J Med (1986) 4.49

The relationship of eosinophilia to intravenous immunoglobulin treatment failure in Kawasaki disease. Pediatr Allergy Immunol (2007) 2.81

Diagnosis and therapy of Kawasaki disease in children. Circulation (1993) 2.32

Kawasaki disease: effect of treatment on coronary artery involvement. Pediatrics (1979) 2.08

The prevention of coronary artery aneurysm in Kawasaki disease: a meta-analysis on the efficacy of aspirin and immunoglobulin treatment. Pediatrics (1995) 1.93

Kawasaki disease: infection, immunity and genetics. Pediatr Infect Dis J (2005) 1.69

Serum albumin level predicts initial intravenous immunoglobulin treatment failure in Kawasaki disease. Acta Paediatr (2010) 1.38

Association of lower eosinophil-related T helper 2 (Th2) cytokines with coronary artery lesions in Kawasaki disease. Pediatr Allergy Immunol (2009) 1.24

CASP3 gene single-nucleotide polymorphism (rs72689236) and Kawasaki disease in Taiwanese children. J Hum Genet (2010) 1.19

Coronary artery fistula associated with Kawasaki disease. Am Heart J (2009) 1.11

Hydrops of the gallbladder associated with Kawasaki syndrome. J Pediatr Surg (1987) 1.04

Assessment of risk factors for Korean children with Kawasaki disease. Pediatr Cardiol (2011) 1.04

Parameters to guide retreatment after initial intravenous immunoglobulin therapy in kawasaki disease. Korean Circ J (2011) 1.03

Intravenous immunoglobulin and salicylate differentially modulate pathogenic processes leading to vascular damage in a model of Kawasaki disease. Arthritis Rheum (2009) 1.02

Too much of a good thing: long-term treatment with salicylate strengthens outer hair cell function but impairs auditory neural activity. Hear Res (2010) 1.02

Clinically useful predictors of resistance to intravenous immunoglobulin and prognosis of coronary artery lesions in patients with incomplete kawasaki disease. Korean Circ J (2014) 0.95

Sonographic gallbladder abnormality is associated with intravenous immunoglobulin resistance in Kawasaki disease. ScientificWorldJournal (2012) 0.88

Prediction of resistance to standard intravenous immunoglobulin therapy in kawasaki disease. Korean Circ J (2014) 0.88

Treatment of acute Kawasaki disease: aspirin's role in the febrile stage revisited. Pediatrics (2004) 0.88

Comparison of high-dose and low-dose aspirin plus intravenous immunoglobulin in the treatment of Kawasaki syndrome. Clin Pediatr (Phila) (2002) 0.87

Inflammation-induced hepcidin is associated with the development of anemia and coronary artery lesions in Kawasaki disease. J Clin Immunol (2012) 0.85

Efficacies and risks of aspirin in the treatment of the Kawasaki disease. Prog Clin Biol Res (1987) 0.84

Is high-dose aspirin necessary in the acute phase of kawasaki disease? Korean Circ J (2013) 0.83

Haemolytic potential of three chemotherapeutic agents and aspirin in glucose-6-phosphate dehydrogenase deficiency. East Mediterr Health J (1999) 0.80

Is there an association between low dose aspirin and anemia (without overt bleeding)? Narrative review. BMC Geriatr (2010) 0.78

Reye's syndrome developing in an infant on treatment of Kawasaki syndrome. J Paediatr Child Health (2005) 0.77

Kawasaki disease with G6PD deficiency--report of one case and literature review. J Microbiol Immunol Infect (2012) 0.77

Asymmetric and symmetric dimethylarginine are associated with coronary artery lesions in Kawasaki disease. J Pediatr (2014) 0.77

Salicylate hepato toxicity in rheumatic fever. Ann Trop Paediatr (1983) 0.77